NCT02773238
FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging
Read More at ClinicalTrials.govInvestigators: Jing Zeng, MD
1570 N 115th Street
Seattle, WA 98133
http://www.sccaprotontherapy.com/ 206.306.2800
1959 NE Pacific Street
Seattle, WA 98195
206.598.4100
Dr. Zeng is a radiation oncologist who specializes in treating patients with lung cancer, thoracic malignancies, and genitourinary tumors, including prostate cancer, using the latest technologies and available clinical trials. She is the Medical Director of the SCCA Proton Therapy Center and practices at UWMC-Montlake and the SCCA Proton Therapy Center.
“The patient-physician relationship should be a team effort, working together to achieve the same goal. As the physician, I will help the patient understand the diagnosis and available treatment options. Ultimately, the patient chooses the treatment path, but it is my duty to ensure that patients have all the information needed to feel confident in the decision. Cancer is a frightening diagnosis, and even though I cannot always cure my patients, I will always care for each one.”
College: Johns Hopkins University, Baltimore, MD, 2003
Medical Education: Duke University, Durham, NC, 2007
Residency: Johns Hopkins Medical Institutions, Baltimore, MD, 2012
FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging
Read More at ClinicalTrials.govInvestigators: Jing Zeng, MD
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer (PARTIQoL)
Read More at ClinicalTrials.govInvestigators: Jing Zeng, MD
TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer
Read More at ClinicalTrials.govInvestigators: Jing Zeng, MD